Rocket Pharmaceuticals Inc (RCKT)
13.98
-0.84
(-5.67%)
USD |
NASDAQ |
Nov 15, 16:00
14.06
+0.08
(+0.57%)
After-Hours: 20:00
Rocket Pharmaceuticals Total Liabilities (Quarterly): 63.92M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 63.92M |
| June 30, 2024 | 61.78M |
| March 31, 2024 | 57.94M |
| December 31, 2023 | 73.77M |
| September 30, 2023 | 57.68M |
| June 30, 2023 | 58.81M |
| March 31, 2023 | 55.88M |
| December 31, 2022 | 62.12M |
| September 30, 2022 | 49.95M |
| June 30, 2022 | 44.16M |
| March 31, 2022 | 42.53M |
| December 31, 2021 | 42.30M |
| September 30, 2021 | 44.58M |
| June 30, 2021 | 45.72M |
| March 31, 2021 | 96.48M |
| December 31, 2020 | 87.30M |
| September 30, 2020 | 93.66M |
| June 30, 2020 | 86.54M |
| March 31, 2020 | 86.70M |
| December 31, 2019 | 64.82M |
| September 30, 2019 | 67.99M |
| Date | Value |
|---|---|
| June 30, 2019 | 60.22M |
| March 31, 2019 | 65.06M |
| December 31, 2018 | 57.28M |
| September 30, 2018 | 51.36M |
| June 30, 2018 | 50.50M |
| March 31, 2018 | 47.02M |
| December 31, 2017 | 54.01M |
| September 30, 2017 | 53.58M |
| June 30, 2017 | 53.54M |
| March 31, 2017 | 54.66M |
| December 31, 2016 | 56.48M |
| September 30, 2016 | 55.08M |
| June 30, 2016 | 4.407M |
| March 31, 2016 | 4.965M |
| December 31, 2015 | 4.508M |
| September 30, 2015 | 3.649M |
| June 30, 2015 | 19.97M |
| March 31, 2015 | 21.57M |
| December 31, 2014 | 57.08M |
| September 30, 2014 | 8.814M |
| December 31, 2013 | 51.76M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
42.30M
Minimum
Dec 2021
96.48M
Maximum
Mar 2021
63.83M
Average
60.29M
Median
Total Liabilities (Quarterly) Benchmarks
| Apellis Pharmaceuticals Inc | 664.74M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 393.69M |
| Shareholders Equity (Quarterly) | 329.77M |